Your browser doesn't support javascript.
loading
Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024.
Vaughan, Aisling M; Afzal, Mohammed; Nannapaneni, Priyanka; Leroy, Mathias; Andrianou, Xanthi; Pires, Jeffrey; Funke, Silvia; Roman, Celine; Reyes-Uruena, Juliana; Aberle, Stephan; Aristodimou, Aristos; Aspelund, Gudrun; Bennet, Kirsty F; Bormane, Antra; Caraglia, Anna; Charles, Hannah; Chazelle, Emilie; Christova, Iva; Cohen, Orna; Constantinou, Costas; Couvreur, Simon; Diaz, Asuncion; Fabiánová, Katerina; Ferraro, Federica; Grenersen, Marte Petrikke; Grilc, Eva; Hannila-Handelberg, Tuula; Hvass, Anne Kathrine; Igoe, Derval; Jansen, Klaus; Janța, Denisa; Kaoustou, Styliani; Koch, Anders; Kosanovic Licina, Mirjana Lana; Krumova, Stefka; Labutin, Anton; Lachmann, Raskit; Lecompte, Amaryl; Lefrançois, Rémi; Leitena, Viktorija; Liitsola, Kirsi; Mlinaric, Ivan; Mor, Zohar; Neary, Martha; Novacek, Alina; Øgle, Magnus Wenstøp; Orlíková, Hana; Papadima, Kalliopi; Rehn, Moa; Sadkowska-Todys, Malgorzata.
Afiliação
  • Vaughan AM; These authors contributed equally as first authors.
  • Afzal M; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Nannapaneni P; These authors contributed equally as first authors.
  • Leroy M; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Andrianou X; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Pires J; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Funke S; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Roman C; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Reyes-Uruena J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Aberle S; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Aristodimou A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Aspelund G; Medical University of Vienna, Centre for Virology, Vienna, Austria.
  • Bennet KF; Medical and Public Health Services, Nicosia, Cyprus.
  • Bormane A; Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland.
  • Caraglia A; United Kingdom Health Security Agency, London, United Kingdom.
  • Charles H; Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia.
  • Chazelle E; Ministry of Health, Rome, Italy.
  • Christova I; United Kingdom Health Security Agency, London, United Kingdom.
  • Cohen O; Santé publique France, the French National Public Health Agency, Saint-Maurice, France.
  • Constantinou C; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • Couvreur S; Division of Epidemiology, Ministry of Health, Jerusalem, Israel.
  • Diaz A; Medical and Public Health Services, Nicosia, Cyprus.
  • Fabiánová K; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Ferraro F; National Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.
  • Grenersen MP; National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia.
  • Grilc E; Ministry of Health, Rome, Italy.
  • Hannila-Handelberg T; Norwegian Institute of Public Health (NIPH), Oslo, Norway.
  • Hvass AK; NIJZ (NIPH), Centre for Communicable Diseases, Ljubljana, Slovenia.
  • Igoe D; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Jansen K; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Janța D; HSE Public Health: National Health Protection Office, Dublin, Ireland.
  • Kaoustou S; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Koch A; National Institute of Public Health, Bucharest, Romania.
  • Kosanovic Licina ML; Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece.
  • Krumova S; Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark.
  • Labutin A; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Lachmann R; Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia.
  • Lecompte A; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • Lefrançois R; Swiss Federal Office of Public Health, Bern, Switzerland.
  • Leitena V; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Liitsola K; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Mlinaric I; Santé publique France, the French National Public Health Agency, Saint-Denis, France.
  • Mor Z; Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia.
  • Neary M; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Novacek A; Croatian Institute of Public Health, Division for Epidemiology of Communicable Diseases, Zagreb, Croatia.
  • Øgle MW; School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel.
  • Orlíková H; Division of Epidemiology, Ministry of Health, Jerusalem, Israel.
  • Papadima K; HSE Health Protection Surveillance Centre, Dublin, Ireland.
  • Rehn M; Austrian Agency for Health and Food Safety, Vienna, Austria.
  • Sadkowska-Todys M; Norwegian Institute of Public Health (NIPH), Oslo, Norway.
Euro Surveill ; 29(27)2024 Jul.
Article em En | MEDLINE | ID: mdl-38967012
ABSTRACT
During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Filogenia / Surtos de Doenças Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Filogenia / Surtos de Doenças Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article